Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Minority Interest: 2014-2025

Historic Minority Interest for vTv Therapeutics (VTVT) over the last 10 years, with Jun 2025 value amounting to -$357,000.

  • vTv Therapeutics' Minority Interest fell 109.01% to -$357,000 in Q2 2025 from the same period last year, while for Jun 2025 it was -$357,000, marking a year-over-year decrease of 109.01%. This contributed to the annual value of $2.1 million for FY2024, which is 65.72% down from last year.
  • As of Q2 2025, vTv Therapeutics' Minority Interest stood at -$357,000, which was down 136.54% from $977,000 recorded in Q1 2025.
  • vTv Therapeutics' 5-year Minority Interest high stood at $62.6 million for Q1 2021, and its period low was -$357,000 during Q2 2025.
  • Over the past 3 years, vTv Therapeutics' median Minority Interest value was $4.6 million (recorded in 2024), while the average stood at $7.0 million.
  • Its Minority Interest has fluctuated over the past 5 years, first skyrocketed by 36.42% in 2023, then crashed by 109.01% in 2025.
  • Quarterly analysis of 5 years shows vTv Therapeutics' Minority Interest stood at $25.0 million in 2021, then slumped by 33.58% to $16.6 million in 2022, then crashed by 63.02% to $6.1 million in 2023, then slumped by 65.72% to $2.1 million in 2024, then crashed by 109.01% to -$357,000 in 2025.
  • Its Minority Interest was -$357,000 in Q2 2025, compared to $977,000 in Q1 2025 and $2.1 million in Q4 2024.